跳至主要内容
临床试验/IRCT20080901001165N57
IRCT20080901001165N57已完成3 期

Investigating the effect of vitamin D3 supplementation in blood pressure control in essential hypertensive patients

Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Essential Hypertension (Systolic pressure > 140 mmHg, Diastolic pressure > 90 mmHg)
  • Adult patients from 18 to 65 y/o
  • Patients under standard Anti-hypertensive agents
  • Vitamin D level is less than 30.

排除标准

  • Heart Failure (LVEF<45%)
  • Renal Failure (Creatinine>1.5mg/dl)
  • Hepatic Failure
  • Chronic Obstructive Pulmonary Disease (COPD): (FEV1/FVC <70%)
  • Thyroid disorders
  • Hyperparathyroidism
  • Systemic infection
  • Hypercalciurea

研究者

发起方
Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences

相似试验